Cobas ASY schedule 66 III clinical analyzers

Ended Awarded Last action

Contract number
HT009026FG018
Awardee
Awarding agency
Obligated
$44,486

Award facts

Contract value 100% obligated
$44,486.18 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
334516 Analytical Laboratory Instrument Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Competed under SAP · 2 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Castleton, IN 46256, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Health Agency issued a BPA call to Roche Diagnostics Corporation on April 6, 2026, for COBAS ASY Schedule 66 III clinical analyzers, with a ceiling value of $44,486.18. The call is issued under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration Schedule contract. Performance occurs in Castleton, Indiana, with completion by September 30, 2026. The order is firm fixed price with no set-aside designation.

Quick answers

Who was awarded contract HT009026FG018?

HT009026FG018 was awarded to Roche Diagnostics Corporation by Defense Health Agency (Department of Defense) on April 6, 2026.

How much is contract HT009026FG018 worth?

The government has obligated $44,486 on HT009026FG018.

Is contract HT009026FG018 an order under another contract?

Yes. HT009026FG018 is a BPA call under FA700025A0014, a blanket purchase agreement.

Was contract HT009026FG018 competed?

The extent of competition for HT009026FG018 was competed under sap. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award